Microchannel Tech Cp (MCTC) 0.0013 $MCTC
BioLight Announces Partnership With Axella Research For CellDetect® Non-Invasive Test for Monitoring Recurrence of Bladder Cancer
PR Newswire - Mon Nov 30, 6:00AM CST
BioLight Life Sciences Investments (OTCQX:BLGTY, TASE:BOLT) ("BioLight" or the "Company"

, announced today that its cancer diagnostics subsidiary, Micromedic Technologies (TASE:MCTC) ("Micromedic"

, has entered into a Collaboration Agreement (the "Agreement"

with Axella Research LLC ("Axella"

, to advance the clinical and regulatory efforts required to commercialize the CellDetect® non-invasive diagnostic test for the monitoring of bladder cancer recurrence in the United States.